(Q44546273)

4 December 2017

Treatment of primary herpes simplex virus infection in guinea pigs by imiquimod (English)

1 reference

4 December 2017

R L Miller

1

1 reference

4 December 2017

L M Imbertson

series ordinal

2

1 reference

4 December 2017

M J Reiter

series ordinal

3

1 reference

4 December 2017

J F Gerster

series ordinal

4

1 reference

4 December 2017

1 November 1999

1 reference

4 December 2017

1 reference

4 December 2017

44

1 reference

4 December 2017

31-42

1 reference

4 December 2017

1

1 reference

Increased genital shedding of herpes simplex virus type 2 in HIV-seropositive women

4 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900052-2

7 January 2021

Effects of the immunomodulating agent R837 on acute and latent herpes simplex virus type 2 infections

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900052-2

7 January 2021

Effects of therapy with an immunomodulator (imiquimod, R-837) alone and with acyclovir on genital HSV-2 infection in guinea-pigs when begun after lesion development

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900052-2

7 January 2021

Adjuvant effects of imiquimod on a herpes simplex virus type 2 glycoprotein vaccine in guinea pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900052-2

7 January 2021

Effect of imiquimod as an adjuvant for immunotherapy of genital HSV in guinea-pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900052-2

7 January 2021

Isolation and characterisation of resistant Herpes simplex virus after acyclovir therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900052-2

7 January 2021

Treatment of recurrent genital herpes with interferon alpha-2alpha.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900052-2

7 January 2021

Analysis of the thymidine kinase gene from clinically isolated acyclovir-resistant herpes simplex viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900052-2

7 January 2021

Two distinct loci confer resistance to acycloguanosine in herpes simplex virus type 1

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900052-2

7 January 2021

Altered substrate specificity of herpes simplex virus thymidine kinase confers acyclovir-resistance

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900052-2

7 January 2021

A Double-Blind Study of Oral Acyclovir for Suppression of Recurrences of Genital Herpes Simplex Virus Infection

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900052-2

7 January 2021

Acyclovir-resistant herpes simplex virus infections in patients with the acquired immunodeficiency syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900052-2

7 January 2021

Herpes simplex virus type 2 in the United States, 1976 to 1994.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900052-2

7 January 2021

Modification of immunological responses and clinical disease during topical R-837 treatment of genital HSV-2 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900052-2

7 January 2021

Effects of cytokines and R-837, a cytokine inducer, on UV-irradiation augmented recurrent genital herpes in guinea pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900052-2

7 January 2021

Posttherapy suppression of genital herpes simplex virus (HSV) recurrences and enhancement of HSV-specific T-cell memory by imiquimod in guinea pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900052-2

7 January 2021

Cytokine induction in hairless mouse and rat skin after topical application of the immune response modifiers imiquimod and S-28463

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900052-2

7 January 2021

The antiviral effects of the interferons and their inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900052-2

7 January 2021

Recognition of herpes simplex virus type 2 tegument proteins by CD4 T cells infiltrating human genital herpes lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900052-2

7 January 2021

Brief report: recurrent acyclovir-resistant genital herpes in an immunocompetent patient.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900052-2

7 January 2021

Imiquimod applied topically: a novel immune response modifier and new class of drug

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900052-2

7 January 2021

Severe genital herpes infections in HIV-infected individuals with impaired herpes simplex virus-specific CD8+ cytotoxic T lymphocyte responses

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900052-2

7 January 2021

In vitro activity of penciclovir against clinical isolates of acyclovir-resistant and foscarnet-resistant herpes simplex virus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900052-2

7 January 2021

Frequency of symptomatic and asymptomatic herpes simplex virus type 2 reactivations among human immunodeficiency virus-infected men.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900052-2

7 January 2021

Imiquimod 5% cream (Aldara).

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900052-2

7 January 2021

Genital Herpes in Guinea Pigs: Pathogenesis of the Primary Infection and Description of Recurrent Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900052-2

7 January 2021

A randomized, controlled, molecular study of condylomata acuminata clearance during treatment with imiquimod.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900052-2

7 January 2021

Modulation of TH1 and TH2 cytokine production with the immune response modifiers, R-848 and imiquimod

1 reference

https://api.crossref.org/works/10.1016%2FS0166-3542%2899%2900052-2

7 January 2021

10.1016/S0166-3542(99)00052-2

Identifiers

DOI

1 reference

4 December 2017

1 reference